Venture capital firm

EDBI portfolio
edbi.comEDBI is a venture capital firm based in Singapore, Singapore, founded in 1991. It has invested in 67 venture-backed companies across 78 funding rounds on VCMC, and led 7 of those rounds. 8 of them were in the last 12 months.
67
Venture-backed companies
in its portfolio on VCMC
78
Funding rounds
led 7
8
Last 12 months
rounds, Oct 2025 to Sep 2026
25
With a disclosed valuation
of 67 companies
$69.3B
Combined value of its private companies
the whole companies, not what EDBI owns
66 private companies EDBI has backed have a VCMC valuation; together they are worth $69.3B. That is the value of the whole companies, not what EDBI owns. Island is 9% of the total. 1 company it backed has since been acquired and is not included. How VCMC values companies.
Values cover private companies only; public companies are not included.
Portfolio
EDBI's most valuable portfolio companies
The 10 most valuable private companies EDBI has backed, by VCMC's valuation. Values cover private companies only; public companies are not included.
- 1 Island Tech Companies, Coppell $6.5B range $5.6B – $9.6B Joined at Series D, 2024
- 2 Lumilens Electronical Components Manufacturing, San Jose $5.8B range $4.8B – $8.2B Joined at Series C, 2026
- 3 Addepar Tech Companies, New York $4.4B range $2.7B – $5.1B Joined at Series G, 2025
- 4 wefox Insurance - Agents, Carriers & Brokers, Zurich $4.0B range $3.2B – $5.2B Joined at Series C, 2021
- 5 Cellares Pharmaceutical Products, South San Francisco $4.0B range $2.3B – $6.1B Joined at Series D, 2026
- 6 d-Matrix Tech Companies, Santa Clara $2.7B range $1.7B – $3.2B Joined at Series C, 2025
- 7 DataRobot Tech Companies, Boston $2.6B range $460M – $8.0B Joined at Series E, 2019
- 8 ElevateBio Pharmaceutical Products, Waltham $2.4B range $693M – $9.9B Joined at Series B, 2020
- 9 Loans & Financing, Singapore $2.2B range $326M – $2.7B Joined at Series D, 2021
- 10 Horizon3.ai Tech Companies, Dover $2.1B range $1.7B – $3.2B Joined at Series E, 2026
Portfolio
Full EDBI portfolio (67 companies)
67 companies. Load more shows the rest.
| # | Last round | History | Range | Trend | Grade | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Magic Leap Tech Companies · since Series D, 2017 | Series G Oct 2021 $500M | $1.7B | $171M – $2.9B | $1.6B (-5%) | $282M | 22% | 1,221 | flat | D | |
| 2 | wefox Insurance - Agents, Carriers & Brokers · since Series C, 2021 | Growth Equity Jul 2025 $178M | $4.0B | $3.2B – $5.2B | $2.6B (-35%) | $461M | 97% | 298 | down | A | |
| 3 | DataRobot Tech Companies · since Series E, 2019 | Series G Jul 2021 $300M | $2.6B | $460M – $8.0B | $2.3B (-11%) | $855M | 48% | 868 | flat | D | |
| 4 | ElevateBio Pharmaceutical Products · since Series B, 2020 | Series D May 2023 $401M | $2.4B | $693M – $9.9B | $1.7B (-30%) | $720M | 79% | 450 | down | D | |
| 5 | Island Tech Companies · since Series D, 2024 | Series F Sep 2026 $400M | $6.5B | $5.6B – $9.6B | $8.3B (+27%) | $915M | 0% | 1,351 | growing | A | |
| 6 | Inari Biotechnology · since Series C, 2019 | Growth Equity Jan 2025 $144M | $1.4B | $738M – $2.5B | $1.0B (-26%) | $167M | 71% | 495 | down | C | |
| 7 | Addepar Tech Companies · since Series G, 2025 | Series G May 2025 $230M | $4.4B | $2.7B – $5.1B | $4.4B (0%) | $483M | 0% | 1,506 | up | B | |
| 8 | Lumilens Electronical Components Manufacturing · since Series C, 2026 | Series C Aug 2026 $700M | $5.8B | $4.8B – $8.2B | $7.2B (+23%) | $788M | 0% | 148 | growing | A | |
| 9 | Cellares Pharmaceutical Products · since Series D, 2026 | Series D Jan 2026 $257M | $4.0B | $2.3B – $6.1B | $4.3B (+8%) | $470M | 0% | 327 | up | B | |
| 10 | UPSIDE Foods Meat Production & Processing · since Series C, 2022 | Series C Apr 2022 $400M | $479M | $102M – $1.5B | $431M (-10%) | $149M | 54% | 230 | flat | D | |
| 11 | Funding Societies Loans & Financing · since Series C, 2022 | Growth Equity Dec 2024 $25M | $237M | $95.3M – $391M | $215M (-10%) | $26.9M | 24% | 481 | flat | C | |
| 12 | Nature's Fynd Food Production · since Series C, 2021 | Series C Jul 2021 $350M | $151M | $88.9M – $473M | $135M (-11%) | $156M | 97% | 92 | shrinking | C | |
| 13 | Druva Tech Companies · since Growth, 2016 | Growth Equity Apr 2021 $147M | $1.9B | $181M – $2.6B | $1.8B (-1%) | $224M | 7% | 1,372 | flat | D | |
| 14 | Seismic Tech Companies · since Series F, 2020 | Series G Aug 2021 $170M | $1.5B | $125M – $1.7B | $1.4B (-4%) | $205M | 0% | 35 | flat | D | |
| 15 | Biofourmis Tech Companies · since Series B, 2019 | Series D Apr 2022 $300M | $229M | $139M – $623M | $192M (-16%) | $186M | 97% | 107 | shrinking | C | |
| 16 | d-Matrix Tech Companies · since Series C, 2025 | Series C Nov 2025 $275M | $2.7B | $1.7B – $3.2B | $2.8B (+2%) | $307M | 0% | 325 | growing | B | |
| 17 | Horizon3.ai Tech Companies · since Series E, 2026 | Series E Aug 2026 $250M | $2.1B | $1.7B – $3.2B | $2.7B (+28%) | $302M | 0% | 645 | growing | A | |
| 18 | Universal Quantum Electronical Components Manufacturing · since Series A, 2026 | Series A Oct 2026 $100M | $523M | $335M – $1.4B | $917M (+75%) | $140M | 0% | 103 | up | C | |
| 19 | Tech Companies · since Growth, 2022 | Growth Equity Jun 2022 $115M | $194M | $126M – $553M | $155M (-20%) | $136M | 97% | 328 | shrinking | C | |
| 20 | Tech Companies · since Seed, 2025 | Series B Aug 2026 $35M | $328M | $261M – $518M | $450M (+37%) | $49.5M | 0% | 38 | growing | B | |
| 21 | Clay & Pottery Products · since Series E, 2021 | Series E Dec 2021 $24M | $86.0M | $14.8M – $453M | $84.0M (-2%) | $35.0M | 64% | 61 | down | D | |
| 22 | Tech Companies · since Series A, 2025 | Series A Jul 2025 $11M | $115M | $40.7M – $175M | $115M (0%) | $16.1M | 0% | 42 | up | C | |
| 23 | Loans & Financing · since Series D, 2021 | Series D Sep 2021 $400M | $2.2B | $326M – $2.7B | $2.1B (-5%) | $329M | 0% | 1,928 | up | D | |
| 24 | Online Marketplace · led at Series C, 2018 | Growth Equity Sep 2021 $100M | $1.1B | $95.6M – $1.3B | $1.1B (0%) | $125M | 2% | 1,230 | flat | D | |
| 25 | Payment Processing & Point of Sale · since Series C, 2023 | Series D Apr 2025 $150M | $2.1B | $1.1B – $2.9B | $2.1B (0%) | $262M | 0% | 573 | up | B | |
| 26 | Decorators & Interior Designers · since Series D, 2020 | Growth Equity Feb 2022 $180M | $1.0B | $94.1M – $1.2B | $1.0B (0%) | $114M | 0% | 7,896 | flat | D | |
| 27 | Biotechnology · since Series B, 2022 | Series C Nov 2025 $115M | $1.4B | $706M – $2.1B | $1.4B (+1%) | $154M | 0% | 139 | up | B | |
| 28 | Tech Companies · since Series C, 2020 | Growth Equity Jul 2022 $200M | $1.9B | $189M – $3.3B | $1.8B (-1%) | $226M | 3% | 805 | flat | D | |
| 29 | Loans & Financing · since Series C, 2022 | Series C Feb 2022 $294M | $519M | $92.3M – $4.0B | $485M (-7%) | $351M | 64% | 88 | flat | D | |
| 30 | Tech Companies · since Series D, 2019 | Series D Feb 2019 $226M | $9.70M | $0 – $9.70M | $9.70M (0%) | – | 100% | 133 | flat | dead | |
| 31 | Medical Research · since Series C, 2026 | Series C Apr 2026 $77M | $801M | $467M – $1.4B | $923M (+15%) | $102M | 0% | 219 | growing | B | |
| 32 | Tech Companies · since Series D, 2018 | Debt Jul 2024 $100M | $984M | $85.9M – $1.8B | $954M (-3%) | $161M | 0% | 368 | up | D | |
| 33 | Investment Consultants & Financial Advisors · led at Growth, 2021 | Growth Equity Oct 2025 $70M | $688M | $440M – $976M | $688M (0%) | $71.2M | 0% | 192 | up | B | |
| 34 | Laboratory Equipment & Supplies · since Series A, 2021 | Series A May 2021 $200M | $1.4B | $63.5M – $2.2B | $1.3B (-8%) | $280M | 0% | 1,296 | flat | D | |
| 35 | Tech Companies · since Series C, 2024 | Series C Aug 2024 $75M | $563M | $380M – $674M | $455M (-19%) | $70.8M | 8% | 214 | growing | A | |
| 36 | Tech Companies · since Series D, 2023 | Series D Jun 2023 $24M | $1.9B | $575M – $2.6B | $1.8B (-4%) | $248M | 0% | 972 | up | C | |
| 37 | Biotechnology · since Series C, 2021 | Series C May 2021 $125M | $301M | $62.8M – $1.4B | $264M (-12%) | $134M | 53% | 85 | up | D | |
| 38 | Payment Processing & Point of Sale · since Bridge, 2020 | Series F Jun 2022 $80M | $667M | $76.5M – $1.7B | $594M (-11%) | $154M | 27% | 947 | flat | D | |
| 39 | Tech Companies · led at Series D, 2026 | Series D Mar 2026 $100M | $899M | $630M – $1.3B | $705M (-22%) | $147M | 97% | 236 | shrinking | B | |
| 40 | Tech Companies · led at Series D, 2026 | Series D Mar 2026 $100M | $869M | $609M – $1.2B | $751M (-14%) | $142M | 97% | 103 | down | B | |
| 41 | Medical Supply Manufacturers · since Series D, 2024 | Series D Jun 2024 $41M | $599M | $148M – $1.0B | $491M (-18%) | $73.8M | 17% | 207 | flat | C | |
| 42 | Media Companies · since Growth, 2017 | Growth Equity Aug 2017 $133M | $705M | $97.1M – $1.7B | $705M (0%) | $146M | 39% | 83 | flat | D | |
| 43 | Medical Supply Manufacturers · since Series C, 2024 | Series D Jul 2026 $65M | $750M | $491M – $1.3B | $905M (+21%) | $108M | 0% | 131 | up | B | |
| 44 | Electronical Components Manufacturing · since Series B, 2023 | Series B Apr 2023 $75M | $241M | $57.9M – $1.0B | $171M (-29%) | $87.1M | 59% | 124 | down | D | |
| 45 | Car Rental · since Series B, 2022 | Series B Feb 2022 $93M | $73.3M | $39.3M – $196M | $67.1M (-8%) | $96.8M | 97% | 188 | shrinking | C | |
| 46 | Tech Companies · since Growth, 2017 | Growth Equity Nov 2017 $65M | $340M | $41.6M – $603M | $340M (0%) | $47.3M | 37% | 1,224 | flat | D | |
| 47 | Pharmaceutical Products · since Series D, 2025 | Series D Jun 2025 $58M | $548M | $333M – $978M | $349M (-36%) | $91.5M | 97% | 30 | shrinking | B | |
| 48 | Electronical Components Manufacturing · since Series C, 2026 | Series C Jun 2026 $80M | $721M | $463M – $1.2B | $855M (+19%) | $94.0M | 0% | 82 | growing | B | |
| 49 | Software Development Services · since Series A, 2024 | Series A Feb 2024 $20M | $222M | $43.4M – $338M | $199M (-10%) | $31.1M | 0% | 152 | up | D | |
| 50 | Health Care Services · led at Series B, 2020 | Series C Aug 2021 $65M | $390M | $45.8M – $658M | $375M (-4%) | $64.6M | 0% | 1,967 | up | D |
Valuation: VCMC's valuation with its range, from a low to a high scenario; a company with no valuation shows a dash, one acquired after its last round its last value as a private company.
Activity
How EDBI invests: stages, industries and countries
Most of its rounds are Series C and later (64%). Its companies span 24 industries, most in Tech Companies, Biotechnology and Electronical Components Manufacturing, across 10 countries.
Rounds by stage
- Seed 2
- Series A 13
- Series B 12
- Series C and later 50
- Other venture 1
Investments by industry
- Tech Companies 24
- Biotechnology 7
- Electronical Components Manufacturing 5
- Payment Processing & Point of Sale 5
- Loans & Financing 3
- Medical Supply Manufacturers 3
- Pharmaceutical Products 3
- Aircraft Parts & Services 1
Investments by country
- United States 35
- Singapore 19
- United Kingdom 3
- Indonesia 2
- Switzerland 2
- Thailand 2
Recent rounds
EDBI's latest investments
EDBI's most recent funding rounds, newest first. 8 rounds in the last 12 months.
- Universal Quantum Series A $100M 8 Oct 2026
- Lumilens Series C $700M 6 Aug 2026
- Horizon3.ai Series E $250M 3 Aug 2026
- Series C $80M 18 Jun 2026
- Series C $77M 30 Apr 2026
- Series D, led $100M 25 Mar 2026
- Series D, led $100M 25 Mar 2026
- Cellares Series D $257M 28 Jan 2026
- d-Matrix Series C $275M 12 Nov 2025
- Series A $11M 9 Jul 2025
Co-investors
EDBI's top co-investors
The investors that most often join the same rounds as EDBI. SoftBank Vision Fund leads, with 9 rounds together.
- SoftBank Vision Fund 9 rounds together
- Goldman Sachs 6 rounds together
- Invus 5 rounds together
- Lightspeed Venture Partners 5 rounds together
- Temasek 5 rounds together
- Sequoia Capital 4 rounds together
- 4 rounds together
- 4 rounds together
- Meritech Capital 3 rounds together
- 3 rounds together
About
About EDBI
EDB Investments Pte Ltd, known as EDBI, is a Singaporean investment company engaged in corporate investment and venture capital activities, with a focus on high-growth technology companies and industry leaders seeking to scale in Singapore and across Asia. The company invests in sectors such as bio-based economy, green economy, next-generation hardware, mobility, health and wellness, and digital economy. EDBI also provides support in areas including market and technology access, research and development collaborations, technology commercialization, strategic development, ecosystem connectivity, and talent support.
Description from Veridion's company data.
- Founded
- 1991
- Based in
- Singapore, Singapore
- Team
- 159 people, -2% in a year
- Type
- Venture capital firm
Focus markets
- Technology
- Healthcare
- Telecommunications
- Biotechnology
What EDBI offers
- Technology Sector Corporate Investment Services
- Startup Scaling and Growth Support Services
- Strategic Investment and Partnership Development
- Technology Commercialization Facilitation
- R&D Collaboration and Innovation Services
- Portfolio Company Development and Financing Services
- Ecosystem Connectivity and Resource Access Services
- Talent Development and Support Services
Questions
EDBI: frequently asked questions
How many companies has EDBI invested in?
67 venture-backed companies on VCMC, across 78 funding rounds.
What are EDBI's most valuable private companies?
Island ($6.5B), Lumilens ($5.8B), Addepar ($4.4B), by VCMC's valuation.
What was EDBI's latest investment?
Universal Quantum, a Series A round in Oct 2026 of $100M.
Which stages does EDBI invest in?
EDBI invests most often at Series C and later (50 rounds), followed by Series A (13) and Series B (12). It has also joined 2 seed and 1 other venture rounds.
What is EDBI's portfolio worth?
Its private companies with a VCMC valuation are worth $69.3B together. That is the sum of the companies' values, not what EDBI owns.
Who does EDBI invest alongside?
SoftBank Vision Fund (9 rounds), Goldman Sachs (6 rounds), Invus (5 rounds).